[Skip to Navigation]
Sign In

Featured Clinical Reviews

April 30, 2019

Is It Time for Safeguards in the Adoption of Robotic Surgery?

Author Affiliations
  • 1Department of Surgery, University of Michigan, Ann Arbor
  • 2Center for Healthcare Outcomes and Policy, Ann Arbor, Michigan
JAMA. 2019;321(20):1971-1972. doi:10.1001/jama.2019.3736

On February 28, 2019, the US Food and Drug Administration (FDA) released a safety communication that cautioned patients, surgeons, and health care organizations about the use of robotic-assisted surgical systems for the management of breast cancer and other cancers.1 This safety communication cited concerns that evidence to support the use of robotic-assisted surgery for the management of these cancers was limited and may even be associated with shorter long-term survival compared with other surgical approaches.

Add or change institution